18-02-2009: Bio Nano Consulting (BNC) and the Nanotechnology Knowledge Transfer Network (NanoKTN) have delivered a highly successful conference in partnership with The Wellcome Trust. The Nano 4 Life conference explored key areas within life sciences where nanotechnology offers opportunities to advance healthcare provision, improve product development and help keep the UK a leading force in this technology area. With high-quality keynote addresses from household names such as GSK, AstraZeneca and GE Healthcare, the event was significantly over-subscribed with greater than 170 registrations.
Nanotechnology is widely recognised to have the potential to make a significant impact on healthcare. The conference successfully brought together leading academic and industry researchers to discuss the increasingly important intersection between nanotechnology and the bio, pharma and healthcare sectors. As bio-nanotechnology experts, BNC organised the Nano 4 Life conference in order to explore how nanotechnology can further benefit life science.
Attendees of the conference heard where the technology can provide solutions to healthcare issues and also what researchers need to consider when developing innovations to ensure that companies can take these new ideas to the patients that need them. The conference had a very positive outlook on how the sector will be able to help solve some of the most pressing healthcare problems, such as drug resistant superbugs and major advances in cancer treatment.
Prof Leonard Fass, Visiting Professor at Imperial College London, one of the Nano 4 Life speakers commented, “It was fantastic to see so many researchers from both academia and industry come together to discuss the applications of nanotechnology in healthcare and pharma.” He continued, “What is more, attendance from such high-profile pharmaceutical companies has helped to highlight the importance of nanotechnology and how it can be used to advance today’s life science sectors.”
Biocartis announces that its researchers, in collaboration with researchers at the Wellcome Trust Sanger Institute and at Philips Research, are developing a novel workflow for extraction and amplification & detection of tumor DNA on Biocartis diagnostic platforms. Biocartis retains its full ... more
Phagenesis Ltd has been awarded c. £1 million from the Wellcome Trust to extend the scope of its dysphagia treatment device, from hospitals into the community. The Phagenesis technology is designed to treat patients who are dysphagic following a stroke.Dysphagia affects more than one mil ... more
Canbex Therapeutics Ltd. announced today that it has received a Translation Award of up to 1.75 million ($2.8 million) from the Wellcome Trust to support development of a drug for the treatment of the debilitating muscle spasms associated with multiple sclerosis and potentially other disord ... more
The Wellcome Trust is the largest charity in the UK. It funds innovative biomedical research, in the UK and internationally, spending around £650 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research an ... more
Bio Nano Consulting (BNC announced the completion of its publicly funded phase of corporate development. At the same time, to mark the company’s transition to a self-supporting and revenue-funded organisation, BNC has unveiled new expanded London offices, acquired to meet the increasing dem ... more
Bio Nano Consulting (BNC) announced the availability of a new technique that screens low-yielding proteins, facilitating the evaluation of both protein denaturation and protein:drug interactions.
This novel method, pioneered by researchers from the UCL Department of Biochemical Engineerin ... more
Bio Nano Consulting (BNC) announced the signing of a service level agreement (SLA) with The School of Pharmacy, University of London. This latest SLA enables BNC to offer an expanded service offering to life science and pharma companies as it provides access to an increased pool of academic ... more
The BNC is a specialist research and development consultancy operating in the convergent field of bionanotechnology. A joint venture of Imperial College London and University College London, the BNC is funded through the Technology Strategy Board (TSB) with additional support from the Londo ... more